Volume 8 Issue 161
Published - 14:00 UTC 08:00 EST 10-Jun-2006 
Next Update - 14:00 UTC 08:00 EST 11-Jun-2006

Editor: Susan K. Boyer, RN
© Vidyya.
All rights reserved.

We subscribe to the HONcode principles. Verify here.

  

 


Study further examines possible cardiovascular effects of ACTOS beyond glycemic control

Researchers today at the American Diabetes Association (ADA) 66th Annual Scientific Sessions presented data showing the relationship between baseline characteristics and cardiac risk factors in patients enrolled in a new clinical trial called CHICAGO (Carotid intima-media tHICkness in Atherosclerosis using pioGlitazOne). This is the largest and longest study to examine the effects of ACTOS on measures of the atherosclerotic disease process in patients with type 2 diabetes, most of whom had no clinical evidence of heart disease. more  

Einstein researchers take the pulse of a gene in living cells

Scientists at the Albert Einstein College of Medicine of Yeshiva University have observed for the first time that gene expression can occur in the form of discrete “pulses” of gene activity. The researchers used pioneering microscopy techniques, developed by Dr. Robert Singer and colleagues at Einstein, that for the first time allow scientists to directly watch the behavior of a single gene in real time. Their findings appeared in the current issue of Current Biology. more

UNMC researchers help make diagnostic breakthrough with Burkitt lymphoma; study detailed in New England Journal of Medicine

An international research study involving the University of Nebraska Medical Center, the National Cancer Institute and 10 other institutions has successfully identified the gene expression signature for Burkitt lymphoma. The discovery, which is reported in the June 8 edition of The New England of Medicine, will allow physicians to better diagnose and treat Burkitt lymphoma and better distinguish it from another more common form of malignant lymphoma. more  

Smokers invited to test vaccine against nicotine addiction

UCSF's Habit Abatement Clinic is testing a vaccine that enlists help from the immune system to keep nicotine away from the brain. The vaccine is designed to help smokers quit and to limit the urge to start smoking again. more

New X-ray delivery method could improve radiation therapy 

Researchers at the U.S. Department of Energy’s Brookhaven National Laboratory and colleagues at Stony Brook University, the IRCCS NEUROMED Medical Center in Italy, and Georgetown University say improvements they have made to an experimental form of radiation therapy that has been under investigation for many years could make the technique more effective and eventually allow its use in hospitals. more

Discovery could aid fight against cystic fibrosis infection  

Harvard Medical School researchers have discovered one way that a hardy disease-causing bacteria could be surviving in the lungs of chronically infected cystic fibrosis (CF) patients. more

Monkeys vaccinated against SIV survive longer after infection

Results of two new studies sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), suggest that even if an HIV vaccine offers imperfect protection against the virus, it might provide vaccinated individuals with an important benefit: a significant survival advantage after infection. more

 

Monkeys vaccinated against SIV survive longer after infection